NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/14/2023
Back to search
Official data from USPTO
CLINICAL AND TRANSLATIONAL SCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL AND TRANSLATIONAL SCIENCE
ST13
US500000086868440Class
9, 41
Filing
86868440
Registration
5293027
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
12/14/2023
Trademark type
Word
Nice classes
9, 41
Filing date
01/07/2016
Registration date
09/19/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/14/2023
Last transaction
12/14/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
04/04/2016
First use in commerce
04/04/2016
Drawing code
4
Owner type
99
Owner location
Alexandria, VA
Examiner
GLASSER, CARYN
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
American Society for Clinical Pharmacology & Therapeutics
Representatives
Gregory M. Stone Whiteford Taylor & Preston, LLP
Technical classification
Nice Classes
Class 9Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable journals in the field of Clinical Translational Science
Class 41
Providing online non-downloadable journals in the field of Clinical Translational Science
Publications
History of USPTO decisions and trademark events.
37 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/14/2023
ES8R
TEAS SECTION 8 RECEIVED
09/19/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/19/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/12/2017
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/19/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/17/2017
ALIE
ASSIGNED TO LIE
08/11/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/01/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2017
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/18/2017
IUAA
USE AMENDMENT ACCEPTED
05/17/2017
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/17/2017
IUAF
USE AMENDMENT FILED
05/17/2017
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/16/2017
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
05/08/2017
ALIE
ASSIGNED TO LIE
05/08/2017
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/08/2017
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/08/2017
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
05/08/2017
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/08/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2016
GNRT
NON-FINAL ACTION E-MAILED
11/15/2016
CNRT
NON-FINAL ACTION WRITTEN
11/15/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/26/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2016
GNRT
NON-FINAL ACTION E-MAILED
04/28/2016
CNRT
NON-FINAL ACTION WRITTEN
04/28/2016
DOCK
ASSIGNED TO EXAMINER
04/22/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2016
NWAP
NEW APPLICATION ENTERED
01/11/2016
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL AND TRANSLATIONAL SCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.